Alexa Hansen

Alexa Hansen is an associate in Covington’s San Francisco office practicing in the area of patent litigation, with an emphasis on pharmaceutical and biological patents.  In addition to her litigation work, she also provides patent analysis for product acquisitions and financial transactions.  Prior to law school, she worked as a medicinal chemist at Merck & Co. designing small molecule drugs.  As a result of her research there, Ms. Hansen is a named inventor on three patents.

Representative Matters

• Representation of Bristol-Myers Squibb in patent litigation in the District of New Jersey against Dr. Reddy’s Laboratories relating to IXEMPRA® Kit, an intravenous infusion treatment for metastatic or locally advanced breast cancer after failure of at least an anthracycline and a taxane. (Bristol-Myers Squibb Company v. Dr. Reddy’s Laboratories Ltd., et al., D. N.J.)
• Represent Fougera Pharmaceuticals Inc., in on-going patent infringement declaratory judgment litigation in which Ms. Hansen was responsible for drafting the invalidity contentions. (Fougera Pharmaceuticals Inc. v. GlycoBioSciences, Inc. 11-CV-01539, D. N.J.).
• Represent Fougera Pharmaceuticals Inc., in on-going Hatch-Waxman litigation, in which Ms. Hansen has taken or second-chaired numerous depositions.  (Fougera Pharmaceuticals Inc. v. Tolmar, Inc. 10-CV-02635, D. N.J.).
• Advise clients on litigation strategy relating to pharmaceutical patent protection.
• Represented Samsung Electronics Co., Ltd. in a patent infringement case involving semiconductor fabrication technologies and memory chip design.  The parties agreed to a settlement after Ms. Hansen helped brief a successful summary judgment motion of noninfringement.  (Advanced Micro Devices, Inc. et al. v. Samsung Electronics Co., Ltd., et al., CV-08-0986 SI, N.D. Cal.).
• Counseled pharmaceutical companies concerning prospective acquisitions of intellectual property relating to pharmaceutical products.
• Provided analysis of pharmaceutical patents for potential investors.
• Negotiated settlement agreement in patent dispute for a financial services provider.

Previous Experience

• Merck & Co., Medicinal Chemist (2004-2006)

Honors and Rankings

• Part of three person 2007-2008 National Champion Team, Saul Lefkowitz Moot Court Competition

Pro Bono

• Represent lesbian from Mexico in asylum proceedings before the Immigration court.
• Represent family from Cambodia in asylum proceedings before the Ninth Circuit and Immigration court.
• Represented Plaintiff class in class action against City of Antioch for civil rights violations.  (Williams, et al. v. City of Antioch, 08-CV-02301-SBA, N.D. Cal.).

Memberships and Affiliations

• Leadership Development Committee - Association of Business Trial Lawyers, Member
• American Bar Association, Member
  • Past Chapter Editor, Annual Review for the IP section
• American Chemical Society, Member
• American Association for the Advancement of Science, Member

Publications and Speeches

• "Power Integrations Case Will Help Shape Damages Theories," Law360 (4/3/2013), Co-Author
• "Unqualified Interests, Definitive Definitions: Washington v. Glucksberg and the Definition of Life," 36 HASTINGS CONST. L.Q. 163 (2008)
• "2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesity," Bioorg. & Med. Chem. Letters 18:4833-4837 (2008), Co-Author